Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
Ibrahim Aldoss(City of Hope), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Gail J. Roboz(Cornell University), Selina M. Luger(University of Pennsylvania), Bijal Shah(Boston College), Nicola Gökbuget(Goethe University Frankfurt), Andre C. Schuh(University of Toronto), Tobias Menne(Newcastle upon Tyne Hospitals NHS Foundation Trust), Nicolas Boissel(Inserm), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Jae H. Park(Memorial Sloan Kettering Cancer Center), R Bassan(Ospedale dell' Angelo), Aaron C. Logan(University of California, San Francisco), Shaun Fleming(Peter MacCallum Cancer Centre)
Cited by 4
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k